Clinical progress and the future of HIV exceptionalism

Archives of Internal Medicine

Volumn 159, Issue 10, 1999, Pages 1042-1048

  Bayer, Ronald ^a,b  

^a University of Columbia   (United States)

^b Teachers College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; NEWBORN SCREENING; PREVALENCE; PRIORITY JOURNAL; REGISTRATION; SCREENING TEST; TREATMENT PLANNING;

ANONYMOUS TESTING; CLINICAL APPROACH/SOURCE; FEDERAL GOVERNMENT; GOVERNMENT REGULATION; HEALTH CARE AND PUBLIC HEALTH; NEW YORK; POLITICAL ACTIVITY; PREGNANT WOMEN; PROFESSIONAL PATIENT RELATIONSHIP; TRENDS; UNITED STATES; VOLUNTARY PROGRAMS;

ANONYMOUS TESTING; ANTI-HIV AGENTS; COMMUNICABLE DISEASE CONTROL; CONFIDENTIALITY; DISEASE NOTIFICATION; FEDERAL GOVERNMENT; FEMALE; FORECASTING; GOVERNMENT REGULATION; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; MALE; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANT WOMEN; SOCIAL CHANGE; UNITED STATES; VOLUNTARY PROGRAMS;

EID: 0033599965     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.10.1042     Document Type: Article

References (45)

1. Rosenberg PS, Biggar RJ. Trends in HIV incidence among young adults in the United States. JAMA. 1998;279:1894-1899.
2. Bayer R. Private Acts Social Consequences: AIDS and the Politics of Public Health. New York, NY: Free Press; 1989.
3. Bayer R. Public health policy and the AIDS epidemic: an end to HIV exceptionalism? N Engl J Med. 1991;324:1500-1504.
4. Bergsma D, ed. Ethical, Social and Legal Dimensions of Screening for Human Genetic Disease. Miami, FIa: Symposia Specialists; 1974.
5. Faden RR, Holtzman NA, Chwalow AJ. Parental rights, child welfare, and public health: the case of PKU screening. Am J Public Health. 1982;72: 1396-1400.
6. Fox D. From TB to AIDS: value conflicts in reporting. Hastings Cent Rep. 1986;16(suppl):11-16.
7. Brandt A. No Magic Bullet. New York, NY: Oxford University Press; 1987.
8. Rettig RA. Health Care Technology: Lessons Learned From the End-Stage Renal Disease Experience. Santa Monica, Calif: RAND; November 1976:1-36. The RAND Paper Series, Publication P-5820.
9. Seltzer C. Moral dimensions of occupational health: the case of the 1969 Coal Mine Health and Safety Act. In: Bayer R. The Health and Safety of Workers. New York, NY: Oxford University Press; 1988: 242-270.
10. Don't take the test. New York Native. October 8-21, 1984:5.
11. Pl Perspective. April 1988:7.
12. Rhame FS, Maki DG. The case for wider use of testing for HIV infection. N Engl J Med. 1989;320: 1248-1254.
13. Scott GB, Hutto C, Makuch RW, et al. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med. 1989;321:1791-1796.
14. Institute of Medicine. HIV Screening of Pregnant Women and Newborns. Washington, DC: National Academy Press; 1991:27.
15. Report of a Consensus Workshop. Early diagnosis of HIV infection in infants, Sienna, Italy, January 17-18,1992. J Acquir Immune Defic Syndr Hum Retrovirol. 1992;5:1169-1178.
16. Working Group on PCP Prophylaxis in Children. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Pep. 1991;40(RR-2):1-13.
17. Heagerty MC, Abrams EJ. Caring for HIV-infected women and children [editorial]. N Engl J Med. 1992;326:887-888.
18. Riley J. A bid to disclose infant HIV tests. New York Newsday. May 26, 1993:6.
19. Riley J. HIV-test bill killed. New York Newsday. June 16, 1993:20.
20. It's OK to tell: parents should know HIV results. New York Newsday. May 27, 1993:64.
21. Navarro M. Testing newborns for AIDS virus raises issue of mother's privacy. New York Times. August 8, 1993:1.
22. AIDS babies pay the price. New York Times. August 13, 1993:A26.
23. New York Governor's Program, Bill No. 123; 1996.
24. Bateman DA, Cooper A, Abrams EJ. Newborn human immunodeficiency virus testing in New York: a legislative quandary. Arch Pediatr Adolesc Med. 1995;149:581-582.
25. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment: Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994; 331:1173-1180.
26. Rovner J. US specialists object to AMA's call for mandatory HIV testing [news]. Lancet. 1996;348: 330.
27. Segel Al. Physicians' attitudes towards human immunodeficiency virus testing in pregnancy. Am J Obstet Gynscol. 1996;174:1750-1754.
28. Minkoff H, Willoughby A. Pediatric HIV disease, zidovudine in pregnancy, and unblinding heel-stick surveys: reframing the debate on prenatal HIV testing. JAMA. 1995;274:1165-1168.
29. Carusi D, Learman LA, Posner SF. Human immunodeficiency virus test refusal in pregnancy: a challenge to voluntary testing. Obstet Gynecol. 1998; 91:540-545.
30. Institute of Medicine. Reducing the Odds: Preventing Perinatal Transmission of HIV in the United States. Washington, DC: National Academy Press; 1998.
31. Shelton DL. Delegates push mandatory HIV testing for pregnant women: American Medical Association House of Delegates vote: annual meeting news. American Medical News. 1996;31:1.
32. Joseph SC. Remarks presented at: V International Conference on AIDS; June 4-9, 1989; Montreal, Quebec.
33. Centers for Disease Control and Prevention. Update: public health surveillance for HIV infection: United States, 1989 and 1990. MMWR Morb Mortal Wkly Rep. 1990;39:853-861.
34. Centers for Disease Control and Prevention. HIV/AIDS Surveill Rep. 1997;8(1).
35. Centers for Disease Control and Prevention. Evaluation of HIV case surveillance through the use of non-name unique identifiers: Maryland and Texas, 1994-1996. MMWR Morb Mortal Wkly Rep. 1998; 46:1254-1258.
36. Gostin LO, Ward JW, Baker AC. National HIV case reporting for the United States: a defining moment in the history of the epidemic. N Engl J Med. 1997;337:1162-1167.
37. Green J, Arno PS. The "Medicaidization" of AIDS: trends in the financing of HIV-related medical care. JAMA. 1990;264:1261-1266.
38. Deeks SG, Smith M, Holodny M, Kahn JO. HIV-1 protease inhibitors: a review for clinicians. JAMA. 1997;277:145-153.
39. Richman DD. HIV therapeutics. Science. 1996; 272:1886-1888.
40. Carton B. New AIDS drug brings hope to Province-town, but unexpected woes. Wall Street Journal. October 3, 1996:A1.
41. Goldstein A. New treatments put AIDS program in a dilemma. Washington Post. August 15,1996:A1.
42. National ADAP [AIDS Drug Assistance Program] Monitoring Project, Interim Technical Report. Menlo Park, Calif: Kaiser Family Foundation; March 1998.
43. Casarett DJ, Lantos JD. Have we treated AIDS too well? rationing and the future of AIDS exceptionalisrn. Ann Intern Med. 1998;128:756-759.
44. Stolberg SG. White House drops plan for Medic-aid to cover cost of AIDS drugs for poor. New York Times. December 6, 1997:14.
45. Birmingham K. Clinton's spending on AIDS care goes awry [news]. Nat Med. 1998;4:138.